The ‘biology winter’ thaws: why investors are buying Hong Kong’s biotech IPOs

--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-01-05 14:00 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Asia, China, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging
--------------------------------------------------------------------
>>> Read full article at South China Morning Post <<<
<-- Back to Home
< >
[Close]